Patents by Inventor Jae Hwy Lee

Jae Hwy Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080166293
    Abstract: Peptides have been discovered which are capable of binding to and internalizing with the human transferrin receptor (hTfR). The sequences HAIYPRH (Seq. ID No. 1) and THRPPMWSPVWP (Seq. ID No. 2) are capable of binding to and internalizing with the human transferrin receptor. When these molecules were fused with other molecules, the fusion product was internalized in cells expressing hTfR. The sequences have use for targeting other peptides and proteins into cells expressing hTfR.
    Type: Application
    Filed: February 18, 2008
    Publication date: July 10, 2008
    Inventors: Jeffrey A. Engler, Jae Hwy Lee, James F. Collawn, Bryan A. Moore
  • Patent number: 6743893
    Abstract: Peptides have been discovered which are capable of binding to and internalizing with the human transferrin receptor (hTfR). The sequences HAIYPRH (Seq. ID No. 1) and THRPPMWSPVWP (Seq. ID No. 2) are capable of binding to and internalizing with the human transferrin receptor. When these molecules were fused with other molecules, the fusion product was internalized in cells expressing hTfR. The sequences have use for targeting other peptides and proteins into cells expressing hTfR.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: June 1, 2004
    Assignee: The UAB Research Foundation
    Inventors: Jeffrey A. Engler, Jae Hwy Lee, James F. Collawn, Bryan A. Moore
  • Publication number: 20020115824
    Abstract: Peptides have been discovered which are capable of binding to and internalizing with the human transferrin receptor (hTfR). The sequences HAIYPRH (Seq. ID No. 1) and THRPPMWSPVWP (Seq. ID No. 2) are capable of binding to and internalizing with the human transferrin receptor. When these molecules were fused with other molecules, the fusion product was internalized in cells expressing hTfR. The sequences have use for targeting other peptides and proteins into cells expressing hTfR.
    Type: Application
    Filed: November 29, 2001
    Publication date: August 22, 2002
    Inventors: Jeffrey A. Engler, Jae Hwy Lee, James F. Collawn, Bryan A. Moore